1 Min Read
Aug 13 (Reuters) - Xvivo Perfusion AB : * Q2 net sales SEK 18.5 million versus SEK 15.8 million * Q2 EBITDA SEK 1.8 million versus SEK 2.4 million * Source text for Eikon * Further company coverage
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.